Meta-analysis of 5 retrospective case series (394 adults with IBD and primary sclerosing cholangitis) of advanced therapies: pooled clinical remission 24.7% at 3 months and 28.6% at 6-12 months; colorectal neoplasia 10.5%. Evidence is limited.
Meta-analysisn = 394
Elzubeir et al. Meta-Analysis: Safety and Effectiveness of Advanced Therapies in Inflammatory Bowel Disease Patients With Concomitant Primary Sclerosing Cholangitis